Neo7Logix Precision Bio-Science
A personalized approach to activate and regulate your immune system to defeat disease
There is significant agreement within the medical community that cancer is a failure of the immune system to do its job of seeking out errant cells and getting rid of them. When the immune system is weaker than normal, the immune system does not always remove the initiating cells that can grow into a tumor. When the immune system is overactive, autoimmune, and neurodegenerative diseases can result. Common neurodegenerative diseases are Parkinson’s and Alzheimer’s. Common autoimmune diseases include rheumatoid arthritis, diabetes type 1, Hashimoto's thyroiditis, systemic lupus erythematosus, and myasthenia gravis.
Why Neo7Logix is different
In a disease process – whether cancer, autoimmune, or neurodegenerative – there are normal and abnormal cell proteins from the patient that can be analyzed and evaluated. The challenge is to identify the ones that are significant. Insignificant proteins are “background noise” that clouds and distracts from the accurate picture of the disease process. However, the proteins that are of tremendous significance give a clear picture of what is needed for effective treatment.
Drug treatments for the general population are considered a success if there is somewhat more than just a 30% response. We do not think that is nearly good enough and we can do better. Neo7Logix does not deliver a one-size-fits-all-approach.
We at Neo7Logix analyze each patient’s immune system to find the immunological problems that have allowed the disease process to occur. After testing and analysis, we identify where the immune system is weak and develop the precise mix of peptides that work to bring the body back to health. An easy way to think of this is that peptides are little molecules with a big job. Peptides help direct the magnitude and preciseness of the immune response.
If you want to restore the ability of your immune system to once again do the job it was designed to do, give Neo7Logix a call for a free 15-minute consultation at +1 (469) 619-7252 for more information.
The Process
Every individual is unique. Even if two people share a disease with the same name, these can be two entirely different disease processes whose only commonality is the name.
Neo7Logix analyzes each patient’s blood and urine. If we are treating a cancer, we also analyze the tumor sample. The results reveal mutations and disease related products related to the patient’s disease that cause the faults or block the patient’s own immune actions of the immune response to fight and regulate against the disease. Neo7logix complete data analysis of the patient reveals the reparative fixes. We then formulate specific and unique peptides that will best reset your immune system to resolve your medical condition. Every patient has an immune fingerprint of susceptibility and strength in disease. Neo7logix types the patient’s immune susceptibility and strengths and selects only the unique peptides related and needed in the reparative fix as a therapeutic treatment.
The Neo7Logix peptide therapy does take some time to manufacture as it is made specifically for each individual patient and therefore unique to that patient. These peptides are built from the ground up in the laboratory de novo (meaning brand new) from pharmaceutical grade amino acids. On average, we will be able to deliver the peptides in 8 to 10 weeks. Our ongoing goal is to significantly shorten this delivery time frame.
We work differently than some other companies. Some have a group of 10-12 peptides which they essentially shuffle around for each patient. Neo7Logix analyzes each individual patient and then builds the peptides specifically for that patient. There are literally tens of billions of potential different peptide combinations available from Neo7Logix.
Safety
The peptides we use are considered GRAS (Generally Recognized as Safe) by the United States Federal government. Peptides are GRAS according to the FDA guidelines, so they have a good safety profile and do not cause serious adverse events as can be seen with other medications. GRAS does not mean approved, though there are FDA approved GRAS peptides in use. Peptides have been around for decades and used safely in humans.
The peptides therapy used by Neo7Logix has IRB (Institutional Review Board) approval for the study design in using the personalized peptide sequences. We are currently in the process to have IND (Investigational New Drug) approval from the FDA.
These peptides are free from any serious adverse events (SAE’s) because they are uniquely matched to the individual's own immune genetics.
The medical literature also establishes this safety of use for peptide immunotherapies. Numerous human based studies in medical literature. (Links)
In cancer treatment, patients are typically given the same combination of drugs even though some drugs will work better for some people than for others. Given the toxicity of chemotherapy drugs, it pays to test ahead of time. But that kind of testing is not routinely done, and the patient will get the one-size-fits-all mix of drugs. This is to be contrasted with having unique peptides such Neo7Logix made specifically for an individual.
These peptides can be also combined with other therapies such as the cancer checkpoint inhibitors such as Keytruda, Opdivo, or Yervoy to boost the effectiveness of these therapies and other small molecule precision target drugs. May also be combined with other complimentary integrative forms of treatment.